Minerva Neurosciences, Inc

Historical 13F Holders

Symbol
NERV
CUSIP
603380205
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 603380205 since 12/18/2024, newest first.

Filer % of Class Filed
Balyasny Asset Management L.P. 13G/A Amendment 2
10.0% 8/14/2026
Event 6/30/2026
Farallon Capital Management, L.L.C. 13G/A Amendment 2
9.7% 8/13/2026
Event 6/30/2026
Federated Hermes, Inc. 13G/A Amendment 1
17.2% 7/8/2026
Event 6/30/2026
Janus Henderson Group PLC 13G 9.9% 5/15/2026
Event 3/31/2026
Balyasny Asset Management L.P. 13G/A Amendment 1
10.0% 5/15/2026
Event 3/31/2026
Coastlands Capital LP 13G
10.0% 2/20/2026
Event 2/13/2026
Balyasny Asset Management L.P. 13G
10.0% 2/17/2026
Event 12/31/2025
Logos Global Management LP 13G
9.9% 2/17/2026
Event 12/23/2025
Adage Capital Management, L.P. 13G
6.4% 2/12/2026
Event 12/31/2025
Farallon Capital Partners, L.P. 13G/A Amendment 1
10.0% 2/5/2026
Event 12/31/2025
Vivo Opportunity Fund Holdings, L.P. 13G
10.0% 12/31/2025
Event 12/23/2025
Federated Hermes, Inc. 13G
19.9% 12/29/2025
Event 12/22/2025
Farallon Capital Partners, L.P. 13G
10.0% 12/29/2025
Event 12/22/2025
Federated Hermes, Inc. 13D
19.3% 10/28/2025
Event 10/21/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 42.5 k $139 k
2026 Q2 58 42.3 M $235 M
2026 Q1 44 38.3 M $231 M
2025 Q4 30 23.1 M $108 M
2025 Q3 23 1.98 M $4.21 M
2025 Q2 22 1.94 M $3.34 M
2025 Q1 21 1.95 M $3.31 M
2024 Q4 23 2.09 M $4.63 M
2024 Q3 22 2.12 M $5.65 M
2024 Q2 22 2.10 M $6.69 M
2024 Q1 23 2.12 M $5.47 M
2023 Q4 21 2.42 M $14.9 M
2023 Q3 20 2.40 M $16.6 M
2023 Q2 19 2.35 M $19.0 M
2023 Q1 17 1.68 M $2.69 M
2022 Q4 21 1.74 M $2.77 M
2022 Q3 26 2.03 M $18.7 M
2022 Q2 24 2.27 M $7.51 M